welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
-
What’s New in Hereditary Colorectal Cancer?This editorial discusses practical sign...
-
Diagnosis, Surveillance, and Treatment Strategies For Familial Adenomatous Polyposis: Rationale and UpdateFamilial adenomatous polyposis is charac...
-
Colonoscopy Prep: TipsAhhh, colon prep! When I had a colon, th...
-
Comparison of Capsule Endoscopy and Magnetic Resonance Imaging for the Detection of Polyps of the Small Intestine in...BACKGROUND AND STUDY AIMS : We have cond...
-
Video Capsule Endoscopy in Familial Adenomatous Polyposis: Capsule Entrapment in an Anal StenosisA 44-year-old woman with familial adenom...
-
Colon Polyps and the Prevention of Colorectal CancerThis book explains colon polyps and thei...
-
Parental Attitudes, Beliefs, and Perceptions About Genetic Testing for FAP and Colorectal Cancer Surveillance in Min...Familial adenomatous polyposis (FAP) is ...